Publikasi Scopus FKUI Tahun 2010 s/d 2020 (data Per 3 Februari 2021)

Pawitan J.A.
6508348067;
Weighting the potential of using tenascin C in diagnosis and therapy of atherosclerosis.
2010
Acta medica Indonesiana
42
2
104
107
1
Department of Histology, Faculty of Medicine, University of Indonesia, Jl. Salemba 6, Jakarta Pusat, 10430, Indonesia
Pawitan, J.A., Department of Histology, Faculty of Medicine, University of Indonesia, Jl. Salemba 6, Jakarta Pusat, 10430, Indonesia
Tenascin is a protein family in the extra cellular matrix (ECM) that consists of four members: tenascin C, tenascin R, tenascin X, and tenascin W. Among the four tenascins, tenascin-C was the first identified and have been the most studied member of the family. In 2006, a patent was registered for a formula containing tenascin C, and the formula has been claimed to be beneficial in treating and preventing vascular diseases such as atherosclerosis. Therefore, this review discusses the structure of tenascin C molecule, its various functions, the possibility of imaging tenascin C expression for diagnosis, the prospect of tenascin C in the therapy of atherosclerosis, and suggestions for further research. This review discusses the structure of tenascin C molecule, its various functions, the potential of imaging tenascin C expression for diagnosis, weighing the prospect of using tenascin C in the therapy of atherosclerosis, and future research suggestions.
recombinant protein; tenascin; atherosclerosis; biosynthesis; blood; differential diagnosis; disease course; human; review; Atherosclerosis; Diagnosis, Differential; Disease Progression; Humans; Recombinant Proteins; Tenascin
01259326
20513936
Review
Q3